A clinical study of a cell-based MAGE-A3 active immunotherapy in advanced melanoma patients
Articolo
Data di Pubblicazione:
2011
Citazione:
A clinical study of a cell-based MAGE-A3 active immunotherapy in advanced melanoma patients / Russo, V.; Lunghi, F.; Fontana, R.; Bregni, M.. - In: JOURNAL OF CANCER. - ISSN 1837-9664. - 2:1(2011), pp. 329-330. [10.7150/jca.2.329]
Abstract:
In this bi-institutional study, twenty-three stage IIIC-IV MAGE-A3+ melanoma patients were vaccinated with M3TK-GML biweekly at three dose levels, with a subsequent phase of vaccinations at the maximum dose level. Anti-MAGE-A3 and anti-TK T cells were as-sessed by in vitro assay and delayed-type hypersensitivity skin testing. © Ivyspring International Publisher.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Immunotherapy; MAGE-A3; Melanoma
Elenco autori:
Russo, V.; Lunghi, F.; Fontana, R.; Bregni, M.
Link alla scheda completa:
Pubblicato in: